SETH LEDERMAN Insider Trading $TNXP Tonix Pharmaceuticals Holding Corp.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for SETH LEDERMAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of SETH LEDERMAN. SETH LEDERMAN is Chief Executive Officer in Tonix Pharmaceuticals Holding Corp. ($TNXP) and President and CEO in Tonix Pharmaceuticals Holding Corp. ($TNXP).
SETH LEDERMAN in Tonix Pharmaceuticals Holding Corp.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of SETH LEDERMAN: President and CEO, Chief Executive Officer
Holdings: 118,267 shares
Current Value: $62,682
Latest Transaction: Jan 04 2021
$TNXP Market Capitalization: $21.31M
$TNXP Previous Close: $0.53
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of SETH LEDERMAN in Tonix Pharmaceuticals Holding Corp.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 04 2021 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Buy | P | 0.68 | 35,000 | 23,800 | 118,267 | 83.3 K to 118.3 K (+42.03 %) |
| Aug 17 2020 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Buy | P | 0.91 | 60,000 | 54,600 | 83,267 | 23.3 K to 83.3 K (+257.88 %) |
| May 06 2020 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Option Exercise | A | 0.96 | 2,000,000 | 1,920,000 | 2,000,000 | |
| May 06 2020 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Option Exercise | A | 0.77 | 2,000,000 | 1,540,000 | 2,000,000 | |
| Dec 04 2019 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Buy | P | 1.16 | 20,000 | 23,180 | 23,267 | 3.3 K to 23.3 K (+612.18 %) |
| May 08 2019 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Option Exercise | A | 2.56 | 129,757 | 332,178 | 129,757 | |
| May 08 2019 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Option Exercise | A | 2.05 | 129,758 | 266,004 | 129,758 | |
| Apr 01 2019 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Buy | P | 2.49 | 5,000 | 12,440 | 32,670 | 27.7 K to 32.7 K (+18.07 %) |
| Mar 28 2019 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Buy | P | 2.38 | 25,000 | 59,375 | 27,670 | 2.7 K to 27.7 K (+936.33 %) |
| Feb 27 2019 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Option Exercise | A | 2.36 | 23,265 | 54,905 | 23,265 | |
| Feb 27 2019 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Option Exercise | A | 1.89 | 23,265 | 43,971 | 23,265 | |
| Jul 02 2018 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Buy | P | 4.64 | 500 | 2,320 | 17,666 | 17.2 K to 17.7 K (+2.91 %) |
| Jun 29 2018 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Buy | P | 4.58 | 500 | 2,290 | 17,166 | 16.7 K to 17.2 K (+3.00 %) |
| Jun 28 2018 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Buy | P | 4.55 | 500 | 2,275 | 16,666 | 16.2 K to 16.7 K (+3.09 %) |
| Jun 14 2018 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Buy | P | 4.37 | 2,000 | 8,740 | 20,463 | 18.5 K to 20.5 K (+10.83 %) |
| Jun 14 2018 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Buy | P | 4.37 | 1,000 | 4,370 | 16,166 | 15.2 K to 16.2 K (+6.59 %) |
| May 30 2018 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Buy | P | 3.17 | 4,000 | 12,680 | 26,700 | 22.7 K to 26.7 K (+17.62 %) |
| Feb 15 2018 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Option Exercise | A | 4.25 | 156,601 | 665,554 | 156,601 | |
| Feb 15 2018 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Option Exercise | A | 3.40 | 156,601 | 532,443 | 156,601 | |
| Dec 27 2017 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Buy | P | 3.61 | 5,300 | 19,133 | 22,700 | 17.4 K to 22.7 K (+30.46 %) |
| Aug 18 2017 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Buy | P | 3.00 | 15,000 | 45,068 | 50,000 | 35 K to 50 K (+42.86 %) |
| Aug 18 2017 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Buy | P | 2.99 | 5,000 | 14,950 | 35,000 | 30 K to 35 K (+16.67 %) |
| Jun 30 2017 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Buy | P | 4.33 | 5,000 | 21,640 | 30,000 | 25 K to 30 K (+20.00 %) |
| Jun 26 2017 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Buy | P | 4.40 | 5,000 | 22,000 | 25,000 | 20 K to 25 K (+25.00 %) |
| Jun 20 2017 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Buy | P | 4.22 | 20,000 | 84,400 | 20,000 | 0 to 20 K |
| Mar 01 2017 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Option Exercise | A | 0.55 | 160,000 | 88,000 | 160,000 | |
| Mar 01 2017 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Option Exercise | A | 0.55 | 160,000 | 88,000 | 160,000 | |
| Nov 22 2016 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Buy | P | 0.43 | 98,000 | 41,924 | 133,000 | 35 K to 133 K (+280.00 %) |
| Oct 31 2016 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Option Exercise | P | 0.63 | 10,000 | 6,300 | 10,000 | |
| Oct 31 2016 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Buy | P | 0.00 | 10,000 | 0 | 90,815 | 80.8 K to 90.8 K (+12.37 %) |
| Jun 22 2016 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Buy | P | 2.08 | 20,000 | 41,500 | 20,000 | 0 to 20 K |
| Jun 21 2016 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Buy | P | 2.00 | 25,000 | 50,000 | 31,000 | 6 K to 31 K (+416.67 %) |
| Mar 23 2016 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Buy | P | 2.44 | 8,000 | 19,537 | 80,815 | 72.8 K to 80.8 K (+10.99 %) |
| Feb 10 2016 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Option Exercise | A | 5.03 | 110,000 | 553,300 | 110,000 | |
| Feb 10 2016 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Option Exercise | A | 5.03 | 110,000 | 553,300 | 110,000 | |
| Sep 25 2015 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Buy | P | 6.50 | 6,000 | 39,000 | 71,074 | 65.1 K to 71.1 K (+9.22 %) |
| Jul 17 2015 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Buy | P | 7.50 | 6,000 | 45,000 | 6,000 | 0 to 6 K |
| Mar 17 2015 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Buy | P | 7.18 | 1,000 | 7,180 | 65,074 | 64.1 K to 65.1 K (+1.56 %) |
| Mar 17 2015 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Buy | P | 6.85 | 1,000 | 6,853 | 64,074 | 63.1 K to 64.1 K (+1.59 %) |
| Mar 13 2015 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Buy | P | 7.21 | 1,000 | 7,210 | 63,074 | 62.1 K to 63.1 K (+1.61 %) |
| Mar 13 2015 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Buy | P | 7.26 | 1,000 | 7,260 | 62,074 | 61.1 K to 62.1 K (+1.64 %) |
| Mar 11 2015 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Buy | P | 7.00 | 1,000 | 7,000 | 61,074 | 60.1 K to 61.1 K (+1.66 %) |
| Mar 11 2015 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Buy | P | 6.90 | 1,000 | 6,900 | 60,074 | 59.1 K to 60.1 K (+1.69 %) |
| Mar 09 2015 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Buy | P | 6.50 | 1,000 | 6,500 | 59,074 | 58.1 K to 59.1 K (+1.72 %) |
| Mar 09 2015 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Buy | P | 6.45 | 1,000 | 6,450 | 58,074 | 57.1 K to 58.1 K (+1.75 %) |
| Mar 05 2015 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Buy | P | 6.48 | 1,000 | 6,480 | 57,074 | 56.1 K to 57.1 K (+1.78 %) |
| Mar 05 2015 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Buy | P | 6.05 | 1,000 | 6,050 | 56,074 | 55.1 K to 56.1 K (+1.82 %) |
| Feb 27 2015 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Option Exercise | A | 5.95 | 7,143 | 42,501 | 7,143 | |
| Feb 27 2015 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Option Exercise | A | 5.95 | 189,000 | 1,124,550 | 189,000 | |
| Feb 09 2015 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Buy | P | 5.85 | 5,000 | 29,250 | 55,074 | 50.1 K to 55.1 K (+9.99 %) |
| Nov 03 2014 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Option Exercise | A | 6.68 | 100,000 | 668,000 | 100,000 | |
| Jun 20 2014 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Option Exercise | A | 9.87 | 100,000 | 987,000 | 100,000 | |
| Mar 21 2014 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Buy | J | 12.15 | 25,000 | 303,750 | 29,167 | 4.2 K to 29.2 K (+599.95 %) |
| Mar 21 2014 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Buy | J | 12.15 | 25,000 | 303,750 | 29,167 | 4.2 K to 29.2 K (+599.95 %) |
| Feb 26 2014 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Option Exercise | A | 15.88 | 71,000 | 1,127,480 | 71,000 | |
| Aug 15 2013 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | President and CEO | Option Exercise | P | 4.25 | 11,765 | 50,001 | 11,765 | |
| Aug 15 2013 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | President and CEO | Buy | P | 0.00 | 11,765 | 0 | 50,074 | 38.3 K to 50.1 K (+30.71 %) |
| May 20 2013 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Buy | P | 7.75 | 400 | 3,100 | 38,309 | 37.9 K to 38.3 K (+1.06 %) |
| May 20 2013 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Buy | P | 7.00 | 600 | 4,200 | 37,909 | 37.3 K to 37.9 K (+1.61 %) |
| Feb 19 2013 | TNXP | Tonix Pharmaceutic ... | LEDERMAN SETH | Chief Executive Off ... | Option Exercise | A | 0.51 | 1,350,000 | 688,500 | 0 |
Page: 1